ATC code D05
{{ATC codes lead|D|05|Antipsoriatics}}
In ATCvet, this subgroup is named "QD05 Drugs for keratoseborrheic disorders".
{{anchor|D05A}}D05A Antipsoriatics for topical use
::In ATCvet, this subgroup is named "QD05A Drugs for keratoseborrheic disorders, topical use".
={{anchor|D05AA}}D05AA [[Tar]]s=
={{anchor|D05AC}}D05AC [[Antracen]] derivatives=
:D05AC01 Dithranol
:D05AC51 Dithranol, combinations
={{anchor|D05AD}}D05AD [[Psoralen]]s for topical use=
:D05AD01 Trioxysalen
:D05AD02 Methoxsalen
={{anchor|D05AX}}D05AX Other antipsoriatics for topical use=
::In ATCvet, this subgroup is named "QD05AX Other drugs for keratoseborrheic disorders for topical use".
:D05AX01 Fumaric acid
:D05AX02 Calcipotriol
:D05AX03 Calcitriol
:D05AX04 Tacalcitol
:D05AX05 Tazarotene
:D05AX06 Roflumilast
:D05AX07 Tapinarof
:D05AX52 Calcipotriol, combinations
:D05AX55 Tazarotene and ulobetasol
{{anchor|D05B}}D05B Antipsoriatics for systemic use
::In ATCvet, this subgroup is named "QD05B Drugs for keratoseborrheic disorders, systemic use".
={{anchor|D05BA}}D05BA Psoralens for systemic use=
={{anchor|D05BB}}D05BB [[Retinoid]]s for treatment of [[psoriasis]]=
:D05BB01 Etretinate
:D05BB02 Acitretin
={{anchor|D05BX}}D05BX Other antipsoriatics for systemic use=
::In ATCvet, this subgroup is named "QD05BX Other drugs for keratoseborrheic disorders for systemic use".
:D05BX51 Fumaric acid derivatives, combinations